Compartir
Información de la revista
Número
Vol. 23. Núm. 3.Páginas 151-248 (septiembre - diciembre 2022)
Originals
Factors influencing the flu/seasonal influenza vaccination rate in the Spanish population at risk according to the 2017 national health survey
Adriana López-Pineda, Andrea Sánchez García, Domingo Orozco-Beltrán, Vicente F. Gil-Guillén, Rauf Nouni-García, Concepción Carratalá-Munuera, Jose A. Quesada
Vacunas. 2022;23:151-8
Study of Meningitis B vaccination schedule on the childhood in Zaragoza
Cristina Genzor Ríos, María Vázquez Sánzchez, David Molina Herranz, María Violeta Fariña Jara, Mónica López Campos, Enrique Llamas Agundez, María Pilar Viñas Viamonte, Carlos Fernández Lozano
Vacunas. 2022;23:159-64
Incidence of herpes zoster and its complications in ≥50-year-old Spanish adults: A prospective cohort study
Luis García Comas, Teresa Cerdán, Maria Del Rosario Cambronero, Juan Antonio García Martínez, Marta López Sanromà, Kusuma Gopala, Benedetto Simone, Javier Díez-Domingo
Vacunas. 2022;23:165-73
Open access
Artículo abierto
Influenza vaccine hesitancy among healthcare workers in Spain: Results of a survey
Carmen Olmedo Lucerón, Aurora Limia Sánchez, Miguel de la Fuente Sánchez, Eva Galindo Moreno, Grupo de Trabajo de Gripe
Vacunas. 2022;23:174-82
Computational analysis of proteome of Foot-and-mouth disease Virus for the prediction of immunogenic epitopes
Manikandan Mohan, Praseetha Sivakumar, Govindasamy Damotharan Dilip, Joseph Christina Rosy, Richard Coico, Krishnan Sundar
Vacunas. 2022;23:183-93
In silico designed novel multi epitope vaccine construct towards Bundibugyo Ebolavirus
Rajaguru Arivuselvam, A. Mohamed Sheik Tharik, S.B. Santhosh, S.N. Meyyanathan, Raman Rajeshkumar
Vacunas. 2022;23:194-207
Special article
Study of the prevention and control campaign for the hepatitis A outbreak in men who have sex with men in Seville (2016–2018)
María Concepción Galdeano Osuna, María Baca Fuentes, Beatriz Jiménez Navajo, Miguel Porras-Povedano
Vacunas. 2022;23:208-14
Review
Preliminary data on messenger RNA (mRNA) vaccines against respiratory syncytial virus
Jordi Reina, María Fernández-Billón
Vacunas. 2022;23:215-21
Genomic instability, origin and evolution of cancer, and personalized immunotherapy
Jorge Maruri, Fernando Martínez-Cortés, Josué Odales, Karen Manoutcharian
Vacunas. 2022;23:222-33
Inferential analysis of the pharmacological properties of the Cervarix® vaccine against papilomavirus
Vilma Amparo Junchaya Yllescas, Javier Juan Aliaga Salguero, Liz Miriam Suarez Reynoso
Vacunas. 2022;23:234-42
Special article
Special Article
Letter to the editor
Is it the time to include transgender women in risk groups for human papillomavirus vaccination?
Jesus Dominguez-Riscart, Isabel Mateo-Gavira, Andres Martin-Aspas
Vacunas. 2022;23:243-4
The global reemergence of human Monkeypox; is mass vaccination essential?
Ali Beheshti Namdar, Masoud Keikha
Vacunas. 2022;23:245-6
The Russo-Ukrainian war crisis and vaccination of Ukrainian refugees as an urgent need
Ali Beheshti Namdar, Masoud Keikha
Vacunas. 2022;23:247-8